Intravenous Immunoglobulin (IVIg) Market Report

Global Intravenous Immunoglobulin (IVIg) Market Professional Research Report 2016-2027, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

  • POSTDATE：Feb 02, 2022
  • PAGES：204
  • REPORT CODE：GMM763222
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Intravenous immunoglobulin refers to the globulin which is specially prepared for intravenous infusion by precipitation and reprocessing of the components extracted from the plasma of healthy people by low-temperature ethanol method to remove the anti-complement activity and inactivate virus by Pasteurization.

    The Intravenous Immunoglobulin (IVIg) Market is expected to grow from USD 10346.0 million in 2020 to USD 28509.37 million by 2025, at a Compound Annual Growth Rate (CAGR) of 13.73% during the forecast period. The research provides insights for the global Intravenous Immunoglobulin (IVIg) market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

    A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Intravenous Immunoglobulin (IVIg) industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Global Intravenous Immunoglobulin (IVIg) Market Segmentations:

    By Players:

    • LFB group

    • Grifols

    • Hualan Biological Engineering Inc

    • Octapharma

    • Takeda Pharmaceuticals

    • Kedrion Biopharma Inc

    • China Biologics Products, Inc

    • ADMA Biologics, Inc

    • Shanghai RAAS Blood Products Co Ltd

    • Baxter International Inc

    • CSL Behring

    By Types:

    • IVIg Liquid

    • IVIg Powder

    By End-User:

    • Immunodeficiency

    • Autoimmune Disease

    • Acute Infection

    By Regions:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • France

    • Italy

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

    • Spain

    • Belgium

    • Poland

    • Russia

    • Turkey

    • Others

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Australia and New Zealand

    • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

    Latin America, Middle East & Africa

    • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

    • Brazil

    • Nigeria

    • South Africa

    • Argentina

    • Others

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Intravenous Immunoglobulin (IVIg) Market

    • 1.3 Market Segmentation by Type

      • 1.3.1 Global Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of IVIg Liquid from 2016 to 2027

      • 1.3.2 Global Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of IVIg Powder from 2016 to 2027

    • 1.4 Market Segmentation by End-Users

      • 1.4.1 Global Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of Immunodeficiency from 2016 to 2027

      • 1.4.2 Global Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of Autoimmune Disease from 2016 to 2027

      • 1.4.3 Global Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of Acute Infection from 2016 to 2027

    • 1.5 Market Segmentation by Regions

      • 1.5.1 North America Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2016 to 2027

        • 1.5.1.1 United States Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2016 to 2027

        • 1.5.1.2 Canada Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2016 to 2027

        • 1.5.1.3 Mexico Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 Europe Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2016 to 2027

        • 1.5.2.1 Germany Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2016 to 2027

        • 1.5.2.2 UK Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2016 to 2027

        • 1.5.2.3 France Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2016 to 2027

        • 1.5.2.4 Italy Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2016 to 2027

        • 1.5.2.5 Nordic Countries Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2016 to 2027

        • 1.5.2.6 Spain Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2016 to 2027

        • 1.5.2.7 Belgium Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2016 to 2027

        • 1.5.2.8 Poland Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2016 to 2027

        • 1.5.2.9 Russia Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2016 to 2027

        • 1.5.2.10 Turkey Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Asia-Pacific Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2016 to 2027

        • 1.5.3.1 China Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2016 to 2027

        • 1.5.3.2 Japan Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2016 to 2027

        • 1.5.3.3 Australia and New Zealand Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2016 to 2027

        • 1.5.3.4 India Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2016 to 2027

        • 1.5.3.5 ASEAN Countries Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2016 to 2027

        • 1.5.3.6 South Korea Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Latin America, Middle East & Africa Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2016 to 2027

        • 1.5.4.1 GCC Countries Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2016 to 2027

        • 1.5.4.2 Brazil Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2016 to 2027

        • 1.5.4.3 Nigeria Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2016 to 2027

        • 1.5.4.4 South Africa Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2016 to 2027

        • 1.5.4.5 Argentina Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints 

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Intravenous Immunoglobulin (IVIg) Market by Types

    • 3.1 Product Development Trends of Different Types

    • 3.2 Commercial Product Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Intravenous Immunoglobulin (IVIg) by Major Types

      • 3.4.1 Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of IVIg Liquid

      • 3.4.2 Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of IVIg Powder

    4 Segmentation of Intravenous Immunoglobulin (IVIg) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Intravenous Immunoglobulin (IVIg) by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Intravenous Immunoglobulin (IVIg) in Immunodeficiency

      • 4.4.2 Market Size and Growth Rate of Intravenous Immunoglobulin (IVIg) in Autoimmune Disease

      • 4.4.3 Market Size and Growth Rate of Intravenous Immunoglobulin (IVIg) in Acute Infection

    5 Market Analysis by Major Regions

    • 5.1 Global Intravenous Immunoglobulin (IVIg) Production Analysis by Major Regions

    • 5.2 Global Intravenous Immunoglobulin (IVIg) Consumption Analysis by Major Regions

    • 5.3 Global Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis 

      • 5.3.2 Europe Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

      • 5.3.4 Latin America, Middle East & Africa Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

    6 Product Commodity of Intravenous Immunoglobulin (IVIg) Market in Major Countries

    • 6.1 Top 5 Export Countries in Intravenous Immunoglobulin (IVIg) market from 2016 to 2021

      • 6.1.1 Top 5 Export Countries' Export Value Analysis in Intravenous Immunoglobulin (IVIg) market from 2016 to 2021

      • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Intravenous Immunoglobulin (IVIg) market from 2016 to 2021

    • 6.2 Top 5 Import Countries in Intravenous Immunoglobulin (IVIg) market from 2016 to 2021

      • 6.2.1 Top 5 Import Countries' Import Value Analysis in Intravenous Immunoglobulin (IVIg) market from 2016 to 2021

      • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Intravenous Immunoglobulin (IVIg) market from 2016 to 2021

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7 North America Intravenous Immunoglobulin (IVIg) Landscape Analysis

    • 7.1 North America Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major Types

    • 7.2 North America Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major End-Users

    • 7.3 North America Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major Countries

      • 7.3.1 United States Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 7.3.2 Canada Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 7.3.3 Mexico Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

    8 Europe Intravenous Immunoglobulin (IVIg) Landscape Analysis

    • 8.1 Europe Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major Types

    • 8.2 Europe Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major End-Users

    • 8.3 Europe Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major Countries

      • 8.3.1 Germany Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 8.3.2 UK Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 8.3.3 France Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 8.3.4 Italy Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 8.3.5 Nordic Countries Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 8.3.6 Spain Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 8.3.7 Belgium Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 8.3.8 Poland Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 8.3.9 Russia Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 8.3.10 Turkey Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

    9 Asia Pacific Intravenous Immunoglobulin (IVIg) Landscape Analysis

    • 9.1 Asia Pacific Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major Types

    • 9.2 Asia Pacific Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major End-Users

    • 9.3 Asia Pacific Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major Countries

      • 9.3.1 China Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 9.3.2 Japan Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 9.3.3 Australia and New Zealand Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 9.3.4 India Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 9.3.5 ASEAN Countries Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 9.3.6 South Korea Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

    10 Latin America, Middle East & Africa Intravenous Immunoglobulin (IVIg) Landscape Analysis

    • 10.1 Latin America, Middle East & Africa Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major Types

    • 10.2 Latin America, Middle East & Africa Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major End-Users

    • 10.3 Latin America, Middle East & Africa Intravenous Immunoglobulin (IVIg) Landscape Analysis by Major Countries

      • 10.3.1 GCC Countries Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 10.3.2 Brazil Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 10.3.3 Nigeria Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

      • 10.3.4 South Africa Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate 

      • 10.3.5 Argentina Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate

    11 Major Players Profile

    • 11.1 LFB group

      • 11.1.1 LFB group Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Grifols

      • 11.2.1 Grifols Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Hualan Biological Engineering Inc

      • 11.3.1 Hualan Biological Engineering Inc Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Octapharma

      • 11.4.1 Octapharma Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Takeda Pharmaceuticals

      • 11.5.1 Takeda Pharmaceuticals Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Kedrion Biopharma Inc

      • 11.6.1 Kedrion Biopharma Inc Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 China Biologics Products, Inc

      • 11.7.1 China Biologics Products, Inc Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

    • 11.8 ADMA Biologics, Inc

      • 11.8.1 ADMA Biologics, Inc Company Profile and Recent Development

      • 11.8.2 Market Performance

      • 11.8.3 Product and Service Introduction

    • 11.9 Shanghai RAAS Blood Products Co Ltd

      • 11.9.1 Shanghai RAAS Blood Products Co Ltd Company Profile and Recent Development

      • 11.9.2 Market Performance

      • 11.9.3 Product and Service Introduction

    • 11.10 Baxter International Inc

      • 11.10.1 Baxter International Inc Company Profile and Recent Development

      • 11.10.2 Market Performance

      • 11.10.3 Product and Service Introduction

    • 11.11 CSL Behring

      • 11.11.1 CSL Behring Company Profile and Recent Development

      • 11.11.2 Market Performance

      • 11.11.3 Product and Service Introduction

    12 Data Source and Research Methodology

    The List of Tables and Figures (Totals 113 Figures and 132 Tables)

    • Figure Product Picture

    • Figure Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of IVIg Liquid from 2016 to 2027

    • Figure Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of IVIg Powder from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2026

    • Figure Global Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of Immunodeficiency from 2016 to 2027

    • Figure Global Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of Autoimmune Disease from 2016 to 2027

    • Figure Global Intravenous Immunoglobulin (IVIg) Market Size and Growth Rate of Acute Infection from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2026

    • Figure North America Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure United States Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Canada Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Mexico Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Europe Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Germany Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure UK Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure France Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Italy Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Nordic Countries Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Spain Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Belgium Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Poland Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Russia Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Turkey Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Asia-Pacific Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure China Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Japan Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Australia and New Zealand Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure India Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure ASEAN Countries Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South Korea Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Latin America, Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure GCC Countries Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Brazil Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Nigeria Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South Africa Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Argentina Intravenous Immunoglobulin (IVIg) Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Intravenous Immunoglobulin (IVIg) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2020

    • Figure Market Share of TOP 5 Players in 2020

    • Figure Market Share of TOP 6 Players from 2016 to 2021

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Intravenous Immunoglobulin (IVIg)

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Intravenous Immunoglobulin (IVIg) by Different Types from 2016 to 2027

    • Table Consumption Share of Intravenous Immunoglobulin (IVIg) by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of IVIg Liquid

    • Figure Market Size and Growth Rate of IVIg Powder

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Intravenous Immunoglobulin (IVIg) by Different End-Users from 2016 to 2027

    • Table Consumption Share of Intravenous Immunoglobulin (IVIg) by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Immunodeficiency

    • Figure Market Size and Growth Rate of Autoimmune Disease

    • Figure Market Size and Growth Rate of Acute Infection

    • Table Global Intravenous Immunoglobulin (IVIg) Production by Major Regions

    • Table Global Intravenous Immunoglobulin (IVIg) Production Share by Major Regions

    • Figure Global Intravenous Immunoglobulin (IVIg) Production Share by Major Regions in 2016

    • Figure Global Intravenous Immunoglobulin (IVIg) Production Share by Major Regions in 2020

    • Figure Global Intravenous Immunoglobulin (IVIg) Production Share by Major Regions in 2026

    • Table Global Intravenous Immunoglobulin (IVIg) Consumption by Major Regions

    • Table Global Intravenous Immunoglobulin (IVIg) Consumption Share by Major Regions

    • Figure Global Intravenous Immunoglobulin (IVIg) Consumption Share by Major Regions in 2016

    • Figure Global Intravenous Immunoglobulin (IVIg) Consumption Share by Major Regions in 2020

    • Figure Global Intravenous Immunoglobulin (IVIg) Consumption Share by Major Regions in 2026

    • Table North America Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

    • Table Europe Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

    • Table Latin America, Middle East & Africa Intravenous Immunoglobulin (IVIg) Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Intravenous Immunoglobulin (IVIg) market from 2016 to 2021

    • Table Top 5 Export Countries' Export Volume Analysis in Intravenous Immunoglobulin (IVIg) market from 2016 to 2021

    • Table Top 5 Import Countries' Import Value Analysis in Intravenous Immunoglobulin (IVIg) market from 2016 to 2021

    • Table Top 5 Import Countries' Import Volume Analysis in Intravenous Immunoglobulin (IVIg) market from 2016 to 2021

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Intravenous Immunoglobulin (IVIg) Consumption by Types from 2016 to 2027

    • Table North America Intravenous Immunoglobulin (IVIg) Consumption Share by Types from 2016 to 2027

    • Figure North America Intravenous Immunoglobulin (IVIg) Consumption Share by Types in 2016

    • Figure North America Intravenous Immunoglobulin (IVIg) Consumption Share by Types in 2020

    • Figure North America Intravenous Immunoglobulin (IVIg) Consumption Share by Types in 2026

    • Table North America Intravenous Immunoglobulin (IVIg) Consumption by End-Users from 2016 to 2027

    • Table North America Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users from 2016 to 2027

    • Figure North America Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users in 2016

    • Figure North America Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users in 2020

    • Figure North America Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users in 2026

    • Table North America Intravenous Immunoglobulin (IVIg) Consumption by Major Countries from 2016 to 2027

    • Table North America Intravenous Immunoglobulin (IVIg) Consumption Share by Major Countries from 2016 to 2027

    • Figure North America Intravenous Immunoglobulin (IVIg) Consumption Share by Major Countries in 2016

    • Figure North America Intravenous Immunoglobulin (IVIg) Consumption Share by Major Countries in 2020

    • Figure North America Intravenous Immunoglobulin (IVIg) Consumption Share by Major Countries in 2026

    • Figure United States Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2016 to 2027

    • Figure Canada Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2016 to 2027

    • Figure Mexico Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2016 to 2027

    • Table Europe Intravenous Immunoglobulin (IVIg) Consumption by Types from 2016 to 2027

    • Table Europe Intravenous Immunoglobulin (IVIg) Consumption Share by Types from 2016 to 2027

    • Figure Europe Intravenous Immunoglobulin (IVIg) Consumption Share by Types in 2016

    • Figure Europe Intravenous Immunoglobulin (IVIg) Consumption Share by Types in 2020

    • Figure Europe Intravenous Immunoglobulin (IVIg) Consumption Share by Types in 2026

    • Table Europe Intravenous Immunoglobulin (IVIg) Consumption by End-Users from 2016 to 2027

    • Table Europe Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users from 2016 to 2027

    • Figure Europe Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users in 2016

    • Figure Europe Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users in 2020

    • Figure Europe Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users in 2026

    • Table Europe Intravenous Immunoglobulin (IVIg) Consumption by Major Countries from 2016 to 2027

    • Table Europe Intravenous Immunoglobulin (IVIg) Consumption Share by Major Countries from 2016 to 2027

    • Figure Europe Intravenous Immunoglobulin (IVIg) Consumption Share by Major Countries in 2016

    • Figure Europe Intravenous Immunoglobulin (IVIg) Consumption Share by Major Countries in 2020

    • Figure Europe Intravenous Immunoglobulin (IVIg) Consumption Share by Major Countries in 2026

    • Figure Germany Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2016 to 2027

    • Figure UK Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2016 to 2027

    • Figure France Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2016 to 2027

    • Figure Italy Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2016 to 2027

    • Figure Nordic Countries Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2016 to 2027

    • Figure Belgium Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2016 to 2027

    • Figure Poland Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2016 to 2027

    • Figure Russia Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2016 to 2027

    • Figure Turkey Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2016 to 2027

    • Table Asia Pacific Intravenous Immunoglobulin (IVIg) Consumption by Types from 2016 to 2027

    • Table Asia Pacific Intravenous Immunoglobulin (IVIg) Consumption Share by Types from 2016 to 2027

    • Figure Asia Pacific Intravenous Immunoglobulin (IVIg) Consumption Share by Types in 2016

    • Figure Asia Pacific Intravenous Immunoglobulin (IVIg) Consumption Share by Types in 2020

    • Figure Asia Pacific Intravenous Immunoglobulin (IVIg) Consumption Share by Types in 2026

    • Table Asia Pacific Intravenous Immunoglobulin (IVIg) Consumption by End-Users from 2016 to 2027

    • Table Asia Pacific Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users from 2016 to 2027

    • Figure Asia Pacific Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users in 2016

    • Figure Asia Pacific Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users in 2020

    • Figure Asia Pacific Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users in 2026

    • Table Asia Pacific Intravenous Immunoglobulin (IVIg) Consumption by Major Countries from 2016 to 2027

    • Table Asia Pacific Intravenous Immunoglobulin (IVIg) Consumption Share by Major Countries from 2016 to 2027

    • Figure Asia Pacific Intravenous Immunoglobulin (IVIg) Consumption Share by Major Countries in 2016

    • Figure Asia Pacific Intravenous Immunoglobulin (IVIg) Consumption Share by Major Countries in 2020

    • Figure Asia Pacific Intravenous Immunoglobulin (IVIg) Consumption Share by Major Countries in 2026

    • Figure China Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2016 to 2027

    • Figure Japan Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2016 to 2027

    • Figure Australia and New ZealandIntravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2016 to 2027

    • Figure India Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2016 to 2027

    • Figure ASEAN Countries Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2016 to 2027

    • Figure South Korea Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2016 to 2027

    • Table Latin America, Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption by Types from 2016 to 2027

    • Table Latin America, Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption Share by Types from 2016 to 2027

    • Figure Latin America, Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption Share by Types in 2016

    • Figure Latin America, Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption Share by Types in 2020

    • Figure Latin America, Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption Share by Types in 2026

    • Table Latin America, Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption by End-Users from 2016 to 2027

    • Table Latin America, Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users from 2016 to 2027

    • Figure Latin America, Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users in 2016

    • Figure Latin America, Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users in 2020

    • Figure Latin America, Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption Share by End-Users in 2026

    • Table Latin America, Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption by Major Countries from 2016 to 2027

    • Table Latin America, Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption Share by Major Countries from 2016 to 2027

    • Figure Latin America, Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption Share by Major Countries in 2016

    • Figure Latin America, Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption Share by Major Countries in 2020

    • Figure Latin America, Middle East & Africa Intravenous Immunoglobulin (IVIg) Consumption Share by Major Countries in 2026

    • Figure GCC Countries Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2016 to 2027

    • Figure Brazil Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2016 to 2027

    • Figure Nigeria Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2016 to 2027

    • Figure South Africa Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2016 to 2027

    • Figure Argentina Intravenous Immunoglobulin (IVIg) Market Volume and Growth Rate from 2016 to 2027

    • Table Company Profile and Development Status of LFB group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of LFB group

    • Figure Sales and Growth Rate Analysis of LFB group

    • Figure Revenue and Market Share Analysis of LFB group

    • Table Product and Service Introduction of LFB group

    • Table Company Profile and Development Status of Grifols

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Grifols

    • Figure Sales and Growth Rate Analysis of Grifols

    • Figure Revenue and Market Share Analysis of Grifols

    • Table Product and Service Introduction of Grifols

    • Table Company Profile and Development Status of Hualan Biological Engineering Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hualan Biological Engineering Inc

    • Figure Sales and Growth Rate Analysis of Hualan Biological Engineering Inc

    • Figure Revenue and Market Share Analysis of Hualan Biological Engineering Inc

    • Table Product and Service Introduction of Hualan Biological Engineering Inc

    • Table Company Profile and Development Status of Octapharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Octapharma

    • Figure Sales and Growth Rate Analysis of Octapharma

    • Figure Revenue and Market Share Analysis of Octapharma

    • Table Product and Service Introduction of Octapharma

    • Table Company Profile and Development Status of Takeda Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Takeda Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Takeda Pharmaceuticals

    • Table Product and Service Introduction of Takeda Pharmaceuticals

    • Table Company Profile and Development Status of Kedrion Biopharma Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Kedrion Biopharma Inc

    • Figure Sales and Growth Rate Analysis of Kedrion Biopharma Inc

    • Figure Revenue and Market Share Analysis of Kedrion Biopharma Inc

    • Table Product and Service Introduction of Kedrion Biopharma Inc

    • Table Company Profile and Development Status of China Biologics Products, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of China Biologics Products, Inc

    • Figure Sales and Growth Rate Analysis of China Biologics Products, Inc

    • Figure Revenue and Market Share Analysis of China Biologics Products, Inc

    • Table Product and Service Introduction of China Biologics Products, Inc

    • Table Company Profile and Development Status of ADMA Biologics, Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of ADMA Biologics, Inc

    • Figure Sales and Growth Rate Analysis of ADMA Biologics, Inc

    • Figure Revenue and Market Share Analysis of ADMA Biologics, Inc

    • Table Product and Service Introduction of ADMA Biologics, Inc

    • Table Company Profile and Development Status of Shanghai RAAS Blood Products Co Ltd

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shanghai RAAS Blood Products Co Ltd

    • Figure Sales and Growth Rate Analysis of Shanghai RAAS Blood Products Co Ltd

    • Figure Revenue and Market Share Analysis of Shanghai RAAS Blood Products Co Ltd

    • Table Product and Service Introduction of Shanghai RAAS Blood Products Co Ltd

    • Table Company Profile and Development Status of Baxter International Inc

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Baxter International Inc

    • Figure Sales and Growth Rate Analysis of Baxter International Inc

    • Figure Revenue and Market Share Analysis of Baxter International Inc

    • Table Product and Service Introduction of Baxter International Inc

    • Table Company Profile and Development Status of CSL Behring

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL Behring

    • Figure Sales and Growth Rate Analysis of CSL Behring

    • Figure Revenue and Market Share Analysis of CSL Behring

    • Table Product and Service Introduction of CSL Behring


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US